Literature DB >> 20733324

Prevalence of chronic nasal symptoms in West Sweden: risk factors and relation to self-reported allergic rhinitis and lower respiratory symptoms.

Jonas Eriksson1, Linda Ekerljung, Teet Pullerits, Kenneth Holmberg, Eva Rönmark, Jan Lötvall, Bo Lundbäck.   

Abstract

BACKGROUND: There are few population-based studies on chronic nasal symptoms and little is known about their prevalence and determinants, or their association with allergic rhinitis and asthma.
METHODS: A questionnaire focused on respiratory symptoms and conditions was mailed in 2008 to 30,000 randomly selected subjects aged 16-75 years in West Sweden, 29,218 could be traced and 18,087 (62%) responded. The questionnaire included questions on self-reported allergic rhinitis, asthma, lower respiratory and nasal symptoms and possible determinants.
RESULTS: Nasal congestion was reported by 14.9% and runny nose by 13.1% of subjects. In total, 19.8% had chronic nasal symptoms. Subjects with chronic nasal symptoms had considerably more symptoms from the lower airways compared with nonrhinitic subjects and vice versa. Forty-seven percent of the subjects with chronic nasal symptoms had concurrent self-reported allergic rhinitis. Several hereditary and environmental factors were associated with chronic rhinitis, including family history of asthma [odds ratio (OR) 1.27; 95% confidence interval 1.07-1.50], family history of allergy (OR 1.74; 1.57-1.92) and current smoking (OR 1.39; 1.25-1.54). Further, chronic nasal symptoms were increasingly prevalent with an increasing degree of urbanization.
CONCLUSION: The prevalence of chronic nasal symptoms in West Sweden was found to be high and strongly associated both with self-reported allergic rhinitis and symptoms from the lower airways. Moreover, several risk factors were identified for chronic nasal symptoms, including family history of allergy and asthma and smoking.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20733324     DOI: 10.1159/000320230

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  12 in total

1.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

2.  Allergic sensitization, rhinitis, and tobacco smoke exposure in U.S. children and adolescents.

Authors:  Josef Shargorodsky; Esther Garcia-Esquinas; Ana Navas-Acien; Sandra Y Lin
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-17       Impact factor: 3.858

3.  Nocturnal nasal obstruction is frequent and reduces sleep quality in patients with obstructive sleep apnea.

Authors:  Maria Värendh; Morgan Andersson; Erla Bjørnsdottir; Harald Hrubos-Strøm; Arne Johannisson; Erna S Arnardottir; Thorarinn Gislason; Sigurdur Juliusson
Journal:  J Sleep Res       Date:  2017-11-06       Impact factor: 3.981

4.  Smoking and prevalence of allergic disorders in Japanese pregnant women: baseline data from the Kyushu Okinawa Maternal and Child Health Study.

Authors:  Keiko Tanaka; Yoshihiro Miyake; Masashi Arakawa
Journal:  Environ Health       Date:  2012-03-14       Impact factor: 5.984

5.  Allergic rhinitis in northern vietnam: increased risk of urban living according to a large population survey.

Authors:  Hoàng Thị Lâm; Nguyễn Văn T Tng; Linda Ekerljung; Eva Rönmark; Bo Lundbäck
Journal:  Clin Transl Allergy       Date:  2011-08-11       Impact factor: 5.871

6.  Allergic Sensitization, Rhinitis and Tobacco Smoke Exposure in US Adults.

Authors:  Josef Shargorodsky; Esther Garcia-Esquinas; Iñaki Galán; Ana Navas-Acien; Sandra Y Lin
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

7.  Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis.

Authors:  Hanna Hisinger-Mölkänen; Päivi Piirilä; Tari Haahtela; Anssi Sovijärvi; Paula Pallasaho
Journal:  World Allergy Organ J       Date:  2018-03-14       Impact factor: 4.084

8.  Chronological changes in rhinitis symptoms present in school-aged children with allergic sensitization.

Authors:  Michelle J Suh; Jin A Park; Suk Won Chang; Jeong Hong Kim; Keun-Hwa Lee; Seong-Chul Hong; Hye-Sook Lee; Ju Wan Kang
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

9.  The gender, age and risk factor distribution differs in self-reported allergic and non-allergic rhinitis: a cross-sectional population-based study.

Authors:  Lucia Cazzoletti; Marcello Ferrari; Mario Olivieri; Giuseppe Verlato; Leonardo Antonicelli; Roberto Bono; Lucio Casali; Isa Cerveri; Pierpaolo Marchetti; Pietro Pirina; Andrea Rossi; Simona Villani; Roberto de Marco
Journal:  Allergy Asthma Clin Immunol       Date:  2015-12-04       Impact factor: 3.406

10.  High prevalence of rhinitis symptoms without allergic sensitization in Estonia and Finland.

Authors:  Paula Pallasaho; Annette Kainu; Maria Juusela; Mari Meren; Anssi Sovijärvi
Journal:  Eur Clin Respir J       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.